In sum, LEPTIN-deficient pigs provide an ideal model to investigate the full spectrum of human NAFLD and develop new strategies for the diagnosis and treatment of NAFLD. This evidence concerns the gene LEP and metabolic dysfunction-associated steatotic liver disease.